Stock Analysis, Dividends, Split History

AMD / Advanced Micro Devices, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price19.98
Volume62,983,200.00
Market Cap ($M)19,275.75
Enterprise Value ($M)19,497.75
Book Value ($M)879.00
Book Value / Share0.90
Price / Book21.93
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 969,110,191
Common Stock Shares Outstanding 967,000,000
Scoring Models
Piotroski F-Score5.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.02
Return on Assets (ROA)0.01
Return on Equity (ROE)0.10
Balance Sheet (mrq) ($M)
Assets4,103.00
Liabilities3,224.00
Quick Ratio1.26
Current Ratio1.66
Income Statement (mra) ($M)
Sales Revenue Goods Net5,329,000,000.00
Sales Revenue Net5,329,000,000.00
Operating Income204.00
Net Income43.00
Earnings Per Share Basic0.04
Earnings Per Share Diluted0.04
Cash Flow Statement (mra) ($M)
Cash From Operations68.00
Cash from Investing-114.00
Cash from Financing-114.00
Identifiers and Descriptors
CUSIP007903107
Central Index Key (CIK)2488
Related CUSIPS
007903957 007903909 007903907 007903958

Split History

Stock splits are used by Advanced Micro Devices, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
AMD: Advanced Micro Devices Stock Analysis and Research Report

2017-09-28 - Asif

We are a global semiconductor company with facilities around the world. Within the global semiconductor industry, we offer primarily: x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit (APU), chipsets, discrete graphics processing units (GPUs) and professional graphics processors; and server and embedded processors, semi-custom System-on-Chip (SoC) products and technology for game consoles. We also license portions of our intellectual property portfolio. In this section, we will describe the general financial condition and the results of operations of Advanced Micro Devices, Inc. and its wholly-owned subsidiaries (collectively, “us,” “our” or “AMD”), including a discussion of our results of operations for the quarter and six months ended July 1, 2017 compared to the quarter and six months ended June 25, 2016 , an analysis of changes in our financial condition and a discussion of our contractual obligations. We believe our fin...

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

Related News Stories

5 Top Stock Trades for Tuesday — Buy AMD, IQ and LULU?

14h investorplace
Broader U.S. equities continued to rally Monday, with some outsized moves in a few specific names. It’s summer trading, and absent a rise in volatility, we could see equities slowly grind higher. Remember, don’t fight price! Here’s a look at our top stock trades for the week. (58-4)

3 Breakout Stocks to Trade This Week

14h investorplace
Equities entered the weekend a stone’s throw from new highs. And with Friday’s rally placing the S&P 500 oh so close to overhead resistance, many stocks are flashing potential breakout patterns. The appeal of breakout stocks is the clean entry and the good chance for follow through. (27-0)

As the Competition Revs, Intel Stock May Be Starting an Epic Slide

18h investorplace
The past few weeks have been tough ones for Intel (NASDAQ:INTC) shareholders, as Intel stock has peeled back from its early June peak of $57.60 to a multi-month low near $47… an 18% setback. But, it can’t be said the punishment wasn’t deserved. (29-2)

Nothing in the Foreseeable Future Can Stop AMD Stock

18h investorplace
When it comes to chipmaker Advanced Micro Devices (NASDAQ:AMD), I have played the part of both the bull and the bear. When AMD stock dropped below $10 in early April 2018, I played the part of the bull, seeing the sell-off as a big buying opportunity for long-term investors into a company with broad exposure to multiple secular growth markets. (23-2)

My Main Takeaway From The Last Week Of Trading Is The Rotation Out Of The Tech Stocks

19h seekingalpha
The week started off with the financial crisis in Turkey rattling investors. Bank shares were smacked as investors worried about the problem spreading to other countries. The Turkish lira traded down as much as 20% vs. the dollar after President Trump authorized the doubling of metal tariffs on the country. Monday was the fourth straight day of losses for the S&P 500. (118-0)

Silicon Investor Message Boards

This table lists all message boards related to AMD / Advanced Micro Devices, Inc. on message board site Silicon Investor.

AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA AMD, ARMH, INTC, NVDA Advanced Micro Devices - Moderated (AMD) Advanced Micro Devices - Moderated (AMD) Advanced Micro Devices - Moderated (AMD)
DOX: Amdocs Limited DOX: Amdocs Limited DOX: Amdocs Limited Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC) Advanced Micro vs Intel (AMD / INTC)
AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated AMD ATI INTC NVDA Moderated MCAMD Motorcyles Centers of America /EUniverse.com MCAMD Motorcyles Centers of America /EUniverse.com MCAMD Motorcyles Centers of America /EUniverse.com
Ameridex Minerals Corp (AMD was NRV) Ameridex Minerals Corp (AMD was NRV) Ameridex Minerals Corp (AMD was NRV) Advanced Micro Devices - Off Topic Advanced Micro Devices - Off Topic Advanced Micro Devices - Off Topic
AMD K6 versus Cyrix M2 AMD K6 versus Cyrix M2 AMD K6 versus Cyrix M2 AMD:News, Press Releases and Information Only! AMD:News, Press Releases and Information Only! AMD:News, Press Releases and Information Only!
CUSIP: 007903107